IFNL cytokines do not modulate human or murine NK cell functions

Area of Science:

• Immunology
• Virology
• Genetics

Background:

• Hepatitis C Virus (HCV) infection outcomes are influenced by genetic factors, including single nucleotide polymorphisms (SNPs) in the Interferon-Lambda (IFNL) gene.
• Previous research indicated a synergistic effect between an IFNL3-associated SNP (rs1299860) and the NK cell gene KIR2DS3, increasing the risk of chronic HCV infection.
• The biological mechanisms underlying this genetic synergy, particularly the interaction between IFNL cytokines and NK cells, require investigation.

Purpose of the Study:

• To investigate whether Interferon-Lambda (IFNL) cytokines regulate natural killer (NK) cell functions.
• To explore a potential biological basis for the observed genetic synergy between IFNL3 and KIR2DS3 in HCV infection.

Main Methods:

• Functional assays were employed to assess NK cell responses.
• Human and murine NK cells were utilized to test for activation, cytokine production, and other functional changes upon exposure to IFNL1, IFNL2, and IFNL3 cytokines.

Main Results:

• No evidence of NK cell activation was found when exposed to IFNL1, IFNL2, or IFNL3 cytokines.
• IFNL cytokines did not inhibit NK cell cytokine production, contrary to preliminary findings.
• These results were consistent across both human and murine NK cells.

Conclusions:

• Interferon-lambda (IFNL) cytokines do not appear to directly regulate NK cell function in the context of HCV infection.
• The biological basis for the previously reported genetic synergy between IFNL3 SNPs and KIR2DS3 in chronic HCV infection requires further research and remains to be elucidated.